PhD, University of Cincinnati, 2018, Engineering and Applied Science: Biomedical Engineering
Myelomeningocele (MMC) is a neurologic defect characterized by failure of neural tube closure in the spinal column. This leads to cerebrospinal fluid leakage or contact with amniotic fluid, which can translate into sexual dysfunctions and paralysis after birth. The recently developed minimally-invasive technique for MMC repair is called fetoscopy, which involves a surgical patch, expanded for defect coverage on the fetus' back. Currently used inert patches do not degrade after implantation, necessitating a post-natal removal surgery, while collagen-based patches employed in are associated with poor mechanical integrity. Also, these patches are not tailored for fetoscopic MMC repair, and their response in fetal environment is unexplored. Deployment and expansion of coiled patch using surgical tools at defect site is time-consuming and cumbersome. Some of these existing patches have mesh-like structure for tissue in-growth, which makes their barrier properties debatable. Upon implantation at defect site, the patch encounters amniotic fluid and body fluids, as well as fluid forces due to fetal movement in the womb. This necessitates analysis of biodegradability and mechanical response of the patch for its adaptability in fetoscopic MMC repair. Taking the above requirements into consideration, we designed a patch comprising a blend of poly (L-lactic acid) (PLA) and poly (ε-caprolactone) (PCL), both polymers approved by the U.S. Food and Drug Administration for hard and soft tissue repair in spine. Different PLA-PCL formulations were characterized for surface and thermal properties, and the ideal formulation was chosen as our designed patch based on aptitude for thermal expansion at in-vivo temperature (37°C). This will enable self-expansion of the coiled patch at defect site, saving time and reducing difficulty level of surgery. The designed patch was characterized for barrier properties to ensure its watertight nature, and for biocompatibility after exposure to huma (open full item for complete abstract)
Committee: Chia-Ying Lin Ph.D. (Committee Chair); Yoonjee Park Ph.D. (Committee Member); Jose Peiro (Committee Member); Marepalli Rao Ph.D. (Committee Member)
Subjects: Biomedical Research